Frédéric Mazurier Selected Research

Frédéric Mazurier Research Topics

Disease

11	Neoplasms (Cancer) 05/2022 - 01/2010
7	Hypoxia (Hypoxemia) 01/2021 - 06/2007
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2022 - 12/2019
3	Xeroderma Pigmentosum (Kaposi's Disease) 01/2022 - 06/2011
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 01/2018
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020 - 12/2019
2	Skin Neoplasms (Skin Cancer) 10/2019 - 01/2011
2	Inflammation (Inflammations) 12/2011 - 09/2011
2	Genomic Instability 06/2011 - 01/2011
2	Neutropenia 11/2006 - 01/2006
1	Carcinogenesis 01/2022
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 04/2019
1	Breast Neoplasms (Breast Cancer) 10/2018
1	Adenocarcinoma 10/2018
1	Carcinoma (Carcinomatosis) 03/2017
1	Leukemia 01/2016
1	Metaplasia 02/2012
1	Atrophy 12/2011
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2011
1	Porphyrias (Porphyria) 06/2008
1	Erythropoietic Porphyria (Congenital Erythropoietic Porphyria) 06/2008
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2005
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2005
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 07/2003

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2010
4	Oxygen (Dioxygen)IBA 01/2016 - 06/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022 - 06/2011
2	A-Form DNA (A-DNA)IBA 01/2022 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2021 - 07/2020
2	AcriflavineIBA 01/2021 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 09/2011 - 06/2007
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2022
1	diphenyleneiodoniumIBA 05/2022
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 01/2021
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2021
1	Differentiation AntigensIBA 01/2021
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2021
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	bcr-abl Fusion ProteinsIBA 01/2021
1	NADP (NADPH)IBA 07/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2019
1	Calcium Channels (Calcium Channel)IBA 04/2019
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 04/2019
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 10/2018
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 03/2017
1	Verapamil (Calan)FDA LinkGeneric 03/2017
1	Epithelial Cell Adhesion MoleculeIBA 03/2017
1	Green Fluorescent ProteinsIBA 02/2012
1	IntegrinsIBA 12/2011
1	Mitochondrial DNA (mtDNA)IBA 01/2011
1	Messenger RNA (mRNA)IBA 01/2010
1	DNA Repair EnzymesIBA 01/2010
1	EnzymesIBA 06/2008
1	Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA 06/2008
1	Heme (Haem)IBA 06/2008
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2006
1	Basic Helix-Loop-Helix Transcription FactorsIBA 10/2005
1	CytokinesIBA 07/2003

Therapy/Procedure

7	Therapeutics 01/2022 - 11/2006
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
1	Radiotherapy 03/2017
1	Subcutaneous Injections 01/2011
1	Transplantation 11/2006
1	Injections 11/2006
1	Autologous Transplantation 01/2006